James E. A. Zlosnik

2.4k total citations
52 papers, 1.7k citations indexed

About

James E. A. Zlosnik is a scholar working on Pulmonary and Respiratory Medicine, Plant Science and Molecular Biology. According to data from OpenAlex, James E. A. Zlosnik has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 24 papers in Plant Science and 20 papers in Molecular Biology. Recurrent topics in James E. A. Zlosnik's work include Cystic Fibrosis Research Advances (33 papers), Bacterial biofilms and quorum sensing (17 papers) and Plant Pathogenic Bacteria Studies (13 papers). James E. A. Zlosnik is often cited by papers focused on Cystic Fibrosis Research Advances (33 papers), Bacterial biofilms and quorum sensing (17 papers) and Plant Pathogenic Bacteria Studies (13 papers). James E. A. Zlosnik collaborates with scholars based in Canada, United States and United Kingdom. James E. A. Zlosnik's co-authors include David P. Speert, Huw D. Williams, Ben Ryall, Trevor J. Hird, John J. LiPuma, Peter Vandamme, Charlotte Peeters, Deborah A. Henry, Theodore Spilker and Jacob G. Bundy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

James E. A. Zlosnik

49 papers receiving 1.7k citations

Peers

James E. A. Zlosnik
Marie‐Christine Groleau Canada
Lea M. Sommer Denmark
Maria van Gennip Denmark
Jens Klockgether Germany
Carmen M. Herrera United States
Lutz Wiehlmann Germany
Henrik Calum Denmark
Ute Schwab United States
Shiwani K. Arora United States
Marie‐Christine Groleau Canada
James E. A. Zlosnik
Citations per year, relative to James E. A. Zlosnik James E. A. Zlosnik (= 1×) peers Marie‐Christine Groleau

Countries citing papers authored by James E. A. Zlosnik

Since Specialization
Citations

This map shows the geographic impact of James E. A. Zlosnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. A. Zlosnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. A. Zlosnik more than expected).

Fields of papers citing papers by James E. A. Zlosnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. A. Zlosnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. A. Zlosnik. The network helps show where James E. A. Zlosnik may publish in the future.

Co-authorship network of co-authors of James E. A. Zlosnik

This figure shows the co-authorship network connecting the top 25 collaborators of James E. A. Zlosnik. A scholar is included among the top collaborators of James E. A. Zlosnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. A. Zlosnik. James E. A. Zlosnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolehmainen, Kathleen, Danielle Jorgensen, Calvin Ka-Fung Lo, et al.. (2025). Series 2: Development of a Multiplex Amplicon Next Generation Sequencing Assay for Rapid Assessment of Resistance-Associated Mutations in M. tuberculosis Clinical Cases. Tropical Medicine and Infectious Disease. 10(7). 194–194.
2.
Russell, Shannon, Michelle Coombe, James E. A. Zlosnik, et al.. (2024). Descriptive Epidemiology and Phylodynamics of the “First Wave” of an Outbreak of Highly Pathogenic Avian Influenza (H5N1 Clade 2.3.4.4b) in British Columbia and the Yukon, Canada, April to September 2022. Transboundary and Emerging Diseases. 2024(1). 2327939–2327939. 4 indexed citations
3.
4.
Sobkowiak, Benjamin, Natalie Prystajecky, James E. A. Zlosnik, et al.. (2023). The utility of SARS-CoV-2 genomic data for informative clustering under different epidemiological scenarios and sampling. Infection Genetics and Evolution. 113. 105484–105484. 1 indexed citations
5.
Russell, Shannon, Kimia Kamelian, John R. Tyson, et al.. (2022). Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population‐based cohort study in British Columbia, Canada. Journal of Medical Virology. 95(1). e28423–e28423. 14 indexed citations
6.
7.
Zlosnik, James E. A., Deborah A. Henry, Trevor J. Hird, et al.. (2020). Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 and 2017. Annals of the American Thoracic Society. 17(12). 1549–1557. 11 indexed citations
8.
Saferali, Aabida, Lisa J. Strug, Bradley S. Quon, et al.. (2020). Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1. PLoS ONE. 15(1). e0227067–e0227067. 11 indexed citations
9.
Waters, Valerie, John J. LiPuma, James E. A. Zlosnik, et al.. (2018). Burkholderia multivorans septicemia in a pediatric liver transplant patient. American Journal of Transplantation. 19(3). 933–938. 1 indexed citations
10.
Vandamme, Peter, Charlotte Peeters, Birgit De Smet, et al.. (2017). Comparative Genomics of Burkholderia singularis sp. nov., a Low G+C Content, Free-Living Bacterium That Defies Taxonomic Dissection of the Genus Burkholderia. Frontiers in Microbiology. 8. 1679–1679. 28 indexed citations
11.
Lee, Amy Huei‐Yi, Stéphane Flibotte, Sunita Sinha, et al.. (2017). Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs. Genome Research. 27(4). 650–662. 37 indexed citations
12.
LaFayette, Shantelle L., Daniel Houle, Trevor Beaudoin, et al.. (2015). Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Science Advances. 1(6). 93 indexed citations
13.
Miller, Ruth R., Trevor J. Hird, Patrick Tang, & James E. A. Zlosnik. (2015). Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis. PLoS ONE. 10(11). e0143472–e0143472. 9 indexed citations
14.
Zlosnik, James E. A., Guohai Zhou, Rollin Brant, et al.. (2014). Burkholderia Species Infections in Patients with Cystic Fibrosis in British Columbia, Canada. 30 Years’ Experience. Annals of the American Thoracic Society. 12(1). 70–78. 74 indexed citations
15.
Ryall, Ben, Marta Carrara, James E. A. Zlosnik, et al.. (2014). The Mucoid Switch in Pseudomonas aeruginosa Represses Quorum Sensing Systems and Leads to Complex Changes to Stationary Phase Virulence Factor Regulation. PLoS ONE. 9(5). e96166–e96166. 38 indexed citations
16.
Behrends, Volker, Thomas J. Bell, Manuel Liebeke, et al.. (2013). Metabolite Profiling to Characterize Disease-related Bacteria. Journal of Biological Chemistry. 288(21). 15098–15109. 37 indexed citations
17.
Peeters, Charlotte, James E. A. Zlosnik, Theodore Spilker, et al.. (2013). Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Systematic and Applied Microbiology. 36(7). 483–489. 105 indexed citations
18.
Huse, Holly, Taejoon Kwon, James E. A. Zlosnik, et al.. (2010). Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations In Vivo. mBio. 1(4). 99 indexed citations
19.
Zlosnik, James E. A., Paulo Sucasas Costa, Rollin Brant, et al.. (2010). Mucoid and Nonmucoid Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Infections. American Journal of Respiratory and Critical Care Medicine. 183(1). 67–72. 66 indexed citations
20.
Zlosnik, James E. A. & David P. Speert. (2010). The Role of Mucoidy in Virulence of Bacteria from theBurkholderia cepaciaComplex: A Systematic Proteomic and Transcriptomic Analysis. The Journal of Infectious Diseases. 202(5). 770–781. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Christine Groleau Breakdown of academic impact, for papers by Lea M. Sommer Breakdown of academic impact, for papers by Maria van Gennip Breakdown of academic impact, for papers by Jens Klockgether Breakdown of academic impact, for papers by Carmen M. Herrera Breakdown of academic impact, for papers by Lutz Wiehlmann Breakdown of academic impact, for papers by Henrik Calum Breakdown of academic impact, for papers by Ute Schwab Breakdown of academic impact, for papers by Shiwani K. Arora
Rankless by CCL
2026